Aspire Health Review

Our assessment

Aspire Health publishes detailed pricing. You get a full dose-by-dose ladder for both compounded drugs, the supply duration of every vial printed beside its price, and a separate brand-name table on the same page. Most sellers here publish one starting figure and let the rest arrive at titration. The one thing Aspire hides is not a price. It is the list of states it serves, which exists only inside a picture.

The dose ladder, rung by rung

Each weight-loss page carries a table with a row per weekly dose. Every row gives the supply duration of one vial and the price of one, two and three vials. The higher rungs are marked as double-strength formulations, and the top row on both drugs reads Inquire rather than carrying a figure.

This is the disclosure that makes a GLP-1 seller comparable at all, because the ladder climbs. The maintenance rungs cost more than the starting ones, and the table shows exactly where the step happens.

It also means nothing here is monthly. A vial that lasts ten weeks is not a month, and neither is one that lasts 4.1 weeks. Each price buys the vial and the number of weeks printed next to it.

Brand names on the same page

Under each compounded ladder sits a smaller table for the FDA-approved product with the same active ingredient: two or three price bands by dose, each for a four-week supply.

Both brand tables end with a note that pricing varies based on insurance coverage and that patients should verify benefits with their insurer. Those figures are conditional in a way the compounded ladder is not, so don't line the two up as if they were the same kind of number.

What the care fee covers, and what it doesn't

A short pricing block under each table says the new patient consultation is free. It then gives a monthly medical care charge covering provider visits, messaging, prescription management and ongoing support, and states that medication is priced separately in the tables above.

Three sentences, and they settle what most sellers here leave ambiguous. The care charge is one bill and the drug is another.

The states are a picture

The contact page has a section headed States We Serve. Under it is an instruction to explore the map to see where the practice is currently licensed, and then an image file named for exactly that.

The image is a labeled United States map with twenty-seven states shaded. No state name appears as text anywhere on the site, so the list cannot be searched, copied, or read by a screen reader. If you cannot see the image, you cannot learn whether you are eligible.

The terms add that availability depends on where providers hold licensure and may change, and that services may run through more than one affiliated entity depending on patient location.

What Aspire does not name

No individual prescribing provider or medical director appears anywhere on the site. The terms describe compounded semaglutide, compounded tirzepatide and certain peptide therapies as prepared by licensed compounding pharmacies, and name none of them.

For a seller this transparent about money, both absences stand out.